Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Hypersensitivity | 5 | 2022 | 883 | 2.070 |
Why?
|
Hypersensitivity | 2 | 2021 | 1093 | 0.860 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 2276 | 0.800 |
Why?
|
Urticaria | 1 | 2022 | 150 | 0.750 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2021 | 182 | 0.640 |
Why?
|
Opioid-Related Disorders | 3 | 2020 | 2062 | 0.600 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 320 | 0.590 |
Why?
|
Back Pain | 1 | 2020 | 545 | 0.560 |
Why?
|
Ribavirin | 1 | 2012 | 395 | 0.370 |
Why?
|
Cholecalciferol | 1 | 2014 | 537 | 0.350 |
Why?
|
Vaccination | 1 | 2021 | 3256 | 0.340 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1606 | 0.320 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2012 | 324 | 0.310 |
Why?
|
Renal Dialysis | 1 | 2014 | 1780 | 0.260 |
Why?
|
Electronic Health Records | 1 | 2022 | 4440 | 0.250 |
Why?
|
Lung Transplantation | 1 | 2012 | 1155 | 0.230 |
Why?
|
Dietary Supplements | 1 | 2014 | 3294 | 0.200 |
Why?
|
Antiviral Agents | 1 | 2012 | 2978 | 0.180 |
Why?
|
Cyclooxygenase 1 | 1 | 2019 | 104 | 0.170 |
Why?
|
Ribosomal Proteins | 2 | 2011 | 360 | 0.160 |
Why?
|
Cross Reactions | 1 | 2019 | 841 | 0.150 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2019 | 371 | 0.150 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 611 | 0.140 |
Why?
|
Administration, Oral | 2 | 2014 | 3913 | 0.130 |
Why?
|
Documentation | 1 | 2022 | 865 | 0.130 |
Why?
|
Viral Vaccines | 1 | 2021 | 636 | 0.130 |
Why?
|
Antigen Presentation | 2 | 2011 | 1284 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1181 | 0.120 |
Why?
|
Anaphylaxis | 1 | 2021 | 746 | 0.120 |
Why?
|
Outpatients | 1 | 2021 | 1483 | 0.120 |
Why?
|
Peptide Biosynthesis | 1 | 2011 | 55 | 0.100 |
Why?
|
Retrospective Studies | 4 | 2022 | 77098 | 0.100 |
Why?
|
Self Report | 1 | 2021 | 3548 | 0.090 |
Why?
|
Immunologic Surveillance | 1 | 2011 | 93 | 0.090 |
Why?
|
Safety | 1 | 2014 | 1185 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3278 | 0.090 |
Why?
|
Neuraminidase | 1 | 2009 | 210 | 0.090 |
Why?
|
Administration, Inhalation | 1 | 2012 | 1104 | 0.090 |
Why?
|
Antigens, Viral | 2 | 2011 | 1034 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15530 | 0.080 |
Why?
|
Middle Aged | 6 | 2021 | 213127 | 0.080 |
Why?
|
Humans | 12 | 2022 | 742088 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2010 | 341 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2011 | 4438 | 0.080 |
Why?
|
Male | 7 | 2021 | 349538 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.080 |
Why?
|
Seawater | 1 | 2007 | 121 | 0.070 |
Why?
|
Monocytes | 2 | 2014 | 2593 | 0.070 |
Why?
|
Chemokines | 1 | 2011 | 954 | 0.070 |
Why?
|
Female | 8 | 2021 | 379592 | 0.070 |
Why?
|
Chronic Disease | 1 | 2022 | 9144 | 0.070 |
Why?
|
Adult | 5 | 2021 | 213712 | 0.070 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2010 | 644 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 457 | 0.070 |
Why?
|
Biodiversity | 1 | 2007 | 341 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3151 | 0.060 |
Why?
|
Fungi | 1 | 2007 | 327 | 0.060 |
Why?
|
Thymus Gland | 1 | 2010 | 1264 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3667 | 0.060 |
Why?
|
Risk Factors | 2 | 2021 | 72145 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 900 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2021 | 21719 | 0.060 |
Why?
|
Ecosystem | 1 | 2007 | 471 | 0.060 |
Why?
|
Dendritic Cells | 2 | 2011 | 2723 | 0.060 |
Why?
|
Protein Biosynthesis | 1 | 2009 | 2126 | 0.050 |
Why?
|
Pilot Projects | 1 | 2014 | 8297 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8328 | 0.050 |
Why?
|
Excipients | 1 | 2021 | 96 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10232 | 0.050 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5519 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2011 | 3465 | 0.040 |
Why?
|
H-2 Antigens | 2 | 2011 | 365 | 0.040 |
Why?
|
Skin Tests | 1 | 2021 | 612 | 0.040 |
Why?
|
Ovalbumin | 2 | 2011 | 719 | 0.040 |
Why?
|
Survival Rate | 1 | 2012 | 12773 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2010 | 4379 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 53187 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16331 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10163 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2021 | 13029 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13256 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10578 | 0.030 |
Why?
|
Time Factors | 1 | 2014 | 40054 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2010 | 11470 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2011 | 718 | 0.020 |
Why?
|
Vaccinia virus | 1 | 2011 | 349 | 0.020 |
Why?
|
Enzyme Stability | 1 | 2009 | 210 | 0.020 |
Why?
|
Receptors, CCR5 | 1 | 2011 | 497 | 0.020 |
Why?
|
Protein Stability | 1 | 2011 | 556 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2011 | 844 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 590 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2020 | 1895 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2010 | 314 | 0.020 |
Why?
|
Oceans and Seas | 1 | 2007 | 50 | 0.020 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2007 | 62 | 0.020 |
Why?
|
Morpholines | 1 | 2011 | 561 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2011 | 5095 | 0.020 |
Why?
|
Signal Transduction | 1 | 2011 | 23387 | 0.020 |
Why?
|
Orthomyxoviridae Infections | 1 | 2009 | 248 | 0.020 |
Why?
|
Protein Folding | 1 | 2009 | 843 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 56350 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1969 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 62966 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.020 |
Why?
|
Aged | 2 | 2020 | 162944 | 0.020 |
Why?
|
Gene Library | 1 | 2007 | 1076 | 0.020 |
Why?
|
Dogs | 1 | 2009 | 3910 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2010 | 2723 | 0.020 |
Why?
|
Adolescent | 1 | 2012 | 85649 | 0.010 |
Why?
|
Protein Transport | 1 | 2009 | 1988 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3701 | 0.010 |
Why?
|
Mice | 4 | 2011 | 81045 | 0.010 |
Why?
|
Epitopes | 1 | 2009 | 2569 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6532 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2011 | 21821 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2011 | 3770 | 0.010 |
Why?
|
Phylogeny | 1 | 2007 | 2797 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 24913 | 0.010 |
Why?
|
Fibroblasts | 1 | 2009 | 4143 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9735 | 0.010 |
Why?
|
Animals | 4 | 2011 | 168561 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 13814 | 0.010 |
Why?
|
Macrophages | 1 | 2011 | 5655 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 18112 | 0.010 |
Why?
|
Computational Biology | 1 | 2007 | 3518 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15994 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14554 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16665 | 0.010 |
Why?
|
United States | 1 | 2020 | 69693 | 0.010 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_